贝塔thalassemia:治疗仍然是一个梦想吗?
Mohammad H Hodroj1, Nathalie Akiki1, Rayan Bou-Fakhredin2
1Division of Hematology and Oncology, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
Minerva medica
|August 3, 2023
概括
贝塔血症是一种遗传性贫血症,具有复杂的临床挑战. 本综述探讨了当前和新兴的治疗方法,包括Luspatercept,以改善患者管理和结果.
科学领域:
- 血液学 血液学 血液学
- 遗传性疾病 遗传性疾病
- 药理学 药理学是指药理学的学科.
背景情况:
- β-thalassemia是一种单一性疾病,由于降低了血红蛋白合成,导致慢性贫血.
- 临床表现不同,并发症包括铁过载和无效的红色素形成.
- 目前的治疗包括输血,铁化和Luspatercept,以及正在研究的永久疗法.
研究的目的:
- 对beta-thalassemia的当前和新型治疗策略进行审查.
- 讨论正在开发中的潜在治愈疗法.
- 为了提供对β-thalassemia管理的概述.
主要方法:
- 对现有和新兴的β-thalassemia治疗方法的文献综述.
- 对保守的管理选择进行分析.
- 探索正在进行的新疗法和治疗疗法的临床试验.
主要成果:
- 已建立的治疗方法,如输血和化,可以控制症状.
- 卢斯帕特塞普特提供了一个新的治疗途径.
- 重要的研究重点是开发更安全,更有效和潜在的治疗方案.
结论:
- 贝塔thalassemia管理需要一个多方面的方法.
- 新型疗法和正在进行的研究有望改善患者的治疗结果.
- 开发治愈策略仍然是一个关键目标.
更多相关视频
07:24A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
1.8K
05:23Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
19.6K
相关概念视频
Bone Marrow Sampling and Transplants
360
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
360
Gene Therapy
25.5K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.5K
Disorders of Erythrocytes
994
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
994
Hemoglobin
3.7K
Hemoglobin is a globular protein made up of four subunits. Two of these subunits are alpha chains, and the other two are beta chains. Each subunit contains a molecule of heme, which has an iron atom and can bind to oxygen. When an oxygen molecule binds to one heme group, it changes the shape of hemoglobin, making it easier for the other heme groups to bind oxygen as well.
When all four heme groups are bound to oxygen, the resulting molecule is called oxyhemoglobin. As a result, arterial blood...
When all four heme groups are bound to oxygen, the resulting molecule is called oxyhemoglobin. As a result, arterial blood...
3.7K
Cystic Fibrosis: Management
194
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
194
iPS Cell Differentiation
2.7K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.7K
